Figure 3From: A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease Proportion (%) of patients in, below, or above the target range of serum phosphorus concentration (2.7-4.5 mg/dL) at 12 weeks.Back to article page